Bio Green Med Solution, Inc. — Director's Dealing 2019

Dec 10, 2019

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Cyclacel Pharmaceuticals, Inc. (CYCC)
CIK: 0001130166
Period of Report: 2019-12-05

Reporting Person: Chiao Judy (V.P., Clin. Dev. & Reg. Aff.)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2019-12-05	Option	$1.74	A	11067	Acquired	2027-12-29	Common Stock (11067)	Direct
2019-12-05	Option	$1.56	A	10182	Acquired	2028-02-22	Common Stock (10182)	Direct

Footnotes

F1: On December 29, 2017, Judy Chiao was granted an option to purchase certain shares of common stock, which option shall vest according to the satisfaction of performance criteria. Certain performance criteria were confirmed to have been met on December 5, 2019, resulting in the vesting of the option as to 11,067 shares.

F2: On February 22, 2018, Judy Chiao was granted an option to purchase certain shares of common stock, which option shall vest according to the satisfaction of performance criteria. Certain performance criteria were confirmed to have been met on December 5, 2019, resulting in the vesting of the option as to 10,182 shares.